Focus | 疾病管制署傳染病

三、 送驗條件對vancomycin感受性降低之金黃色葡萄球菌，即MIC≧2μg/mL。 註：CLSI之M100-S21標準(Jan. 2011)，S. aureus/Vancomycin Breakpoints ... Read More

2013年12月31日 — 本案例報告描述一住院中發生VISA (vancomycin intermediate-resistant. S. aureus) 菌血症病人，在給予linezolid 合併sodium fusidate、rifampin ... Read More

由 WA McGuinness 著作 · 2017 · 被引用 353 次 — Vancomycin, a glycopeptide antibiotic that inhibits cell wall biosynthesis, remains a drug of choice for treatment of severe MRSA infections. S. Read More

Vancomycin-resistant Staphylococcus aureus (VRSA) are strains of Staphylococcus aureus that have become resistant to the glycopeptide antibiotic​ ... Read More

由 WA McGuinness 著作 · 2017 · 被引用 350 次 — S. aureus isolates with complete resistance to vancomycin (MIC ≥ 16 µg/mL) are termed vancomycin-resistant S. aureus (VRSA)—they were first ... Read More

由 PS Loomba 著作 · 2010 · 被引用 182 次 — Vancomycin has been regarded as the first-line drug for treatment of MRSA. Unfortunately there has been an increase in the use of this antibiotic for other ... Read More

由 Y Cong 著作 · 2020 · 被引用 64 次 — Vancomycin remains one of the first-line drugs for the treatment of MRSA infections. However, S. aureus isolates with complete resistance to ... Read More

由 Y Cong 著作 · 2020 · 被引用 64 次 — Vancomycin remains one of the first-line drugs for the treatment of MRSA infections. However, S. aureus isolates with complete resistance to vancomycin have ... Read More

由 K Al-Amery 著作 · 2019 · 被引用 24 次 — The emergence of vancomycin-resistant Staphylococcus aureus (VRSA) represents a challenge for the treatment of staphylococcal infections in ... Read More

由 A Shariati 著作 · 2020 · 被引用 14 次 — Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus (VISA) and heterogeneous VISA (hVISA) are ... Read More